Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|March 12, 2021
Blastic Plasmacytoid Dendritic Cell Neoplasm: Single Center Experience on a Rare Hematological MalignancyZehra Narli Ozdemir, Guldane Cengiz Seval, Ugur Sahin, et al.
European Journal of Haematology|December 29, 2019
A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myelomaRoman Hajek, Ludek Pour, Muhit Ozcan, et al.
Leukemia Research|January 22, 2005
Expression of IFITM1 in chronic myeloid leukemia patientsCemaliye Boylu Akyerli, Meral Beksac, Michelle Holko, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 30, 2025
Immune Checkpoint Molecule Expression, 9p24.1 Gene Alterations, and Tumor Microenvironment of Primary Central Nervous System Lymphomas and Their Clinical RelevanceDilara Akbulut, Seher Yuksel, Ekin Kircali, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 12, 2022
Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic LeukemiaZehra Narli Ozdemir, Ekin Kircali, Uğur Şahin, et al.
British Journal of Haematology|September 1, 2018
Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapyJan Walewski, Andrzej Hellmann, Noppadol Siritanaratkul, et al.
Clinical Transplantation|July 27, 2020
Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantationPinar Ataca Atilla, Erman Akkus, Erden Atilla, et al.
Antiviral Therapy|July 5, 2018
Is cytomegalovirus a risk factor for haemorrhagic cystitis in allogeneic haematopoietic stem cell transplantation recipients?Erden Atilla, Merih Yalciner, Pinar Ataca Atilla, et al.
Blood Advances|November 8, 2021
Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort dataLaurie H Sehn, Mark Hertzberg, Stephen Opat, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|November 9, 2002
Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yieldTaner Demirer, Osman Ilhan, Meltem Ayli, et al.
Pageof 5